Literature DB >> 19571100

American academy of orthopaedic surgeons clinical practice guideline on. Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty.

Norman A Johanson, Paul F Lachiewicz, Jay R Lieberman, Paul A Lotke, Javad Parvizi, Vincent Pellegrini, Theodore A Stringer, Paul Tornetta, Robert H Haralson, William C Watters.   

Abstract

Entities:  

Year:  2009        PMID： 19571100     DOI： 10.2106/JBJS.I.00511

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN： 0021-9355            Impact factor:   5.284


× No keyword cloud information.
  42 in total

Review 1.  Aspirin for lower limb arthroplasty thromboprophylaxis: review of international guidelines.

Authors:  C L Donohoe; M K Sayana; R Thakral; D M Niall
Journal:  Ir J Med Sci       Date:  2010-12-14       Impact factor: 1.568

2.  Association between aspirin use and deep venous thrombosis in mechanically ventilated ICU patients.

Authors:  Ena Gupta; Furqan S Siddiqi; Ryan Kunjal; Muhammad Faisal; Farah Al-Saffar; Abubakr A Bajwa; Lisa M Jones; Vandana Seeram; James D Cury; Adil Shujaat
Journal:  J Thromb Thrombolysis       Date:  2017-10       Impact factor: 2.300

3.  No Difference Between Low- and Regular-dose Aspirin for Venous Thromboembolism Prophylaxis After THA.

Authors:  Mhamad Faour; Nicolas S Piuzzi; David P Brigati; Alison K Klika; Michael A Mont; Wael K Barsoum; Carlos A Higuera
Journal:  Clin Orthop Relat Res       Date:  2019-02       Impact factor: 4.176

4.  The use of warfarin for DVT prophylaxis following hip and knee arthroplasty: how often are patients within their target INR range?

Authors:  Denis Nam; Anita Sadhu; Jeffrey Hirsh; James A Keeney; Ryan M Nunley; Robert L Barrack
Journal:  J Arthroplasty       Date:  2014-09-06       Impact factor: 4.757

5.  Thrombophylaxis with low-dose, short-term fondaparinux after elective hip surgery.

Authors:  Kosuke Tsuda; Takashi Nishii; Takashi Sakai; Masaki Takao; Nobuo Nakamura; Nobuhiko Sugano
Journal:  J Thromb Thrombolysis       Date:  2016-04       Impact factor: 2.300

6.  Thromboprophylaxis in multiple myeloma: is the evidence there?

Authors:  Sigurdur Yngvi Kristinsson; Ola Landgren
Journal:  Expert Rev Anticancer Ther       Date:  2012-03       Impact factor: 4.512

7.  Low risk of thromboembolic complications with tranexamic acid after primary total hip and knee arthroplasty.

Authors:  Blake P Gillette; Lori J DeSimone; Robert T Trousdale; Mark W Pagnano; Rafael J Sierra
Journal:  Clin Orthop Relat Res       Date:  2013-01       Impact factor: 4.176

8.  Anticoagulation Bridging Therapy Patterns in Patients Undergoing Total Hip or Total Knee Replacement in a US Health Plan: Real-World Observations and Implications.

Authors:  Onur Baser; Dylan Supina; Nishan Sengupta; Li Wang
Journal:  Am Health Drug Benefits       Date:  2011-07

9.  Plasma accumulation of fondaparinux 2.5 mg in patients after total hip arthroplasty.

Authors:  Yohei Yukizawa; Yutaka Inaba; Shin-Ichiro Watanabe; Satoshi Yajima; Naomi Kobayashi; Takashi Ishida; Naoyuki Iwamoto; Choe Hyonmin; Mashio Nakamura; Tomoyuki Saito
Journal:  J Thromb Thrombolysis       Date:  2012-11       Impact factor: 2.300

10.  Natural course of asymptomatic deep venous thrombosis in hip surgery without pharmacologic thromboprophylaxis in an Asian population.

Authors:  Kosuke Tsuda; Tomio Kawasaki; Nobuo Nakamura; Hideki Yoshikawa; Nobuhiko Sugano
Journal:  Clin Orthop Relat Res       Date:  2010-01-08       Impact factor: 4.176
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.